Chigenovo

Biotechnology company focused on developing gene therapy drugs for eye diseases

placeChangping District, Beijing, China calendar_todayFounded 2016 language chigenovo.com

Innovation

17 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 191 times.

YearFilings
20212
20226
20236
20248
20256
20265

Investor mix

7 investors on record; lead investors include Longmen Capital, Lotus Lake Capital Management, Kunlun Capital.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%
Coming soon